Search Results

Involvement of hypothalamic peptides in the anorectic action of the CB1 receptor antagonist rimonabant (SR 141716).

• Authors : Verty, Aaron N. A. (AUTHOR); Boon, Wee M. (AUTHOR); Mallet, Paul E. (AUTHOR)

Subjects: EFFECT of drugs on appetite; APPETITE loss; HYPOTHALAMUS physiology

• Source: European Journal of Neuroscience. Jun2009, Vol. 29 Issue 11, p2207-2216. 10p. 1 Color Photograph, 1 Chart, 3 Graphs.

Record details

The novel MAGL inhibitor MJN110 enhances responding to reward-predictive incentive cues by activation of CB1 receptors.

• Authors : Feja, Malte¹ (AUTHOR) ; Leigh, Martin P.K.¹ (AUTHOR) ; Baindur, Ajay N.¹ (AUTHOR)

Subjects: *OREXINS; *RIMONABANT; *SUCROSE

• Source: Neuropharmacology. Jan2020, Vol. 162, pN.PAG-N.PAG. 1p.

Record details

The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific.

• Authors : Niyuhire, Floride; Varvel, Stephen A.; Thorpe, Andrew J.

Subjects: DRUG side effects; SHORT-term memory; CONDITIONED response

• Source: Psychopharmacology; Apr2007, Vol. 191 Issue 2, p223-231, 9p, 1 Chart, 3 Graphs

Record details

Context-Specific Reversal of Cocaine Sensitization by the CB1 Cannabinoid Receptor Antagonist Rimonabant.

• Authors : Gerdeman, Gregory L; Schechter, Jason B; French, Edward D

• Source: Neuropsychopharmacology; Oct2008, Vol. 33 Issue 11, p2747-2759, 13p, 5 Charts

Record details

Extinction learning of rewards in the rat: is there a role for CB1 receptors?

• Authors : Hernandez, Giovanni; Cheer, Joseph

Subjects: CANNABINOIDS; FOOD consumption; LABORATORY rats

• Source: Psychopharmacology; Sep2011, Vol. 217 Issue 2, p189-197, 9p

Record details

Rimonabant: endocannabinoid inhibition for the metabolic syndrome.

• Authors : WIERZBICKI, A. S.

Subjects: OBESITY treatment; METABOLIC syndrome; WEIGHT loss

• Source: International Journal of Clinical Practice; Dec2006, Vol. 60 Issue 12, p1697-1706, 10p, 2 Diagrams, 2 Charts

Record details

Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state.

• Authors : Rea, Kieran; Ford, Gemma K.; Olango, Weredeselam M.

Subjects: MICROINJECTIONS; CHRONIC pain; GLYCERIN

• Source: European Journal of Neuroscience. Feb2014, Vol. 39 Issue 3, p435-443. 9p. 2 Diagrams, 1 Chart, 5 Graphs.

Record details

Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.

• Authors : Gamble-George, Joyonna; Conger, Jordan; Hartley, Nolan

Subjects: CANNABINOID receptors; ANXIETY; PHARMACOLOGY

• Source: Psychopharmacology; Aug2013, Vol. 228 Issue 3, p401-409, 9p, 2 Graphs

Record details

Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats.

• Authors : Füllhase, Claudius; Schreiber, Andrea; Giese, Armin

• Source: Neurourology & Urodynamics; Apr2016, Vol. 35 Issue 4, p464-470, 7p

Record details

Hypothalamic cannabinoid signaling: Consequences for eating behavior.

• Authors : Lord, Magen N.; Noble, Emily E.

Subjects: DIETARY patterns; REGULATION of body weight; FOOD habits

• Source: Pharmacology Research & Perspectives; Oct2024, Vol. 12 Issue 5, p1-11, 11p

Record details